Sharon Bryant, MBA MSc

2025S

• 323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1
• 323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1
• 323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
• 323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 - (2 Courses)
• 323105 VU Innovation & Leadership in Preclinical Drug Development - MPS5

2024W

• 323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1
• 323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1
• 323003 VO Basics of Drug Discovery - MPS2
• 323004 VO Drug Discovery - MPS3
• 323005 VO Preclinical Drug Development - MPS4

2024S

• 323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1
• 323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1
• 323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
• 323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 - (2 Courses)
• 323105 VU Innovation & Leadership in Preclinical Drug Development - MPS5